HVIA
CDMO

Hudson Valley Investment Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Hudson Valley Investment Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,414
Closed -$10K – 153
2017
Q2 		$10K Buy
+2,414
New +$9.88K ﹤0.01% 146

Other funds holding CDMO

TSP
Tappan Street Partners Chicago, Illinois $35.7M AUM 42.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return

Hudson Valley Investment Advisors's CDMO Position: Q3 2017 in Review

Hudson Valley Investment Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2017, closing a stake of 2,414 shares — an estimated $10K sold.

Hudson Valley Investment Advisors first reported a position in CDMO in Q2 2017 and held it in 1 quarter. The position peaked at $10K in Q2 2017. 53 funds tracked by Wall St. Rank hold CDMO as of Q3 2017.

  • Hudson Valley Investment Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Hudson Valley Investment Advisors sold 2,414 Avid Bioservices, Inc. Common Stock shares in Q3 2017, an estimated $10K.
  • Hudson Valley Investment Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2017 and held it in 1 quarter.
  • Hudson Valley Investment Advisors's Avid Bioservices, Inc. Common Stock position peaked at $10K in Q2 2017.
  • 53 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2017.

Based on Hudson Valley Investment Advisors's 13F filing for Q3 2017, filed 13 Oct 2017.